Intuitive Surgical, Inc. (ISRG)
Automate Your Wheel Strategy on ISRG
With Tiblio's Option Bot, you can configure your own wheel strategy including ISRG - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ISRG
- Rev/Share 26.9546
- Book/Share 47.7905
- PB 12.1368
- Debt/Equity 0.0
- CurrentRatio 4.7279
- ROIC 0.1402
- MktCap 205836196238.0
- FreeCF/Share 6.3693
- PFCF 90.6248
- PE 74.8017
- Debt/Assets 0.0
- DivYield 0
- ROE 0.1608
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 3
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ISRG | Erste Group | Buy | Hold | -- | -- | July 23, 2025 |
| Downgrade | ISRG | Deutsche Bank | Hold | Sell | -- | $440 | June 9, 2025 |
| Upgrade | ISRG | Erste Group | Hold | Buy | -- | -- | June 5, 2025 |
News
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
ALC or ISRG: Which Is the Better Value Stock Right Now?
Published: November 04, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Instruments stocks have likely encountered both Alcon (ALC) and Intuitive Surgical, Inc. (ISRG). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Intuitive Surgical Stock To $700?
Published: November 04, 2025 by: Forbes
Sentiment: Positive
Intuitive Surgical (ISRG) has been on a powerful run, fueled by rising adoption of its da Vinci robotic systems and steady growth in surgical procedure volumes worldwide. The stock has outpaced both the S&P 500 and the broader medtech sector, underscoring investor confidence in its leadership within robotic-assisted surgery.
Read More
$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Published: November 03, 2025 by: MarketBeat
Sentiment: Positive
Insider buying is often considered a bullish signal because those who know the company the best are loading up on shares. It suggests that positive developments are on the horizon—which could lead to a rally—or that the insider sees long-term value in a stock.
Read More
ISRG Rides on da Vinci 5 Momentum: Can This Growth Sustain?
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical's Q3 results impress, with da Vinci 5 adoption driving 23% revenue growth, though sustaining this rapid momentum may pose new challenges ahead.
Read More
Top 3 Stocks Powering Through Trump's Tariff Policies
Published: October 28, 2025 by: MarketBeat
Sentiment: Neutral
Since President Trump entered office, tariffs have become among the most discussed topics in financial markets. April 2, which became known as “Liberation Day.
Read More
Baron Health Care Fund Q3 2025 Top Contributors And Detractors
Published: October 27, 2025 by: Seeking Alpha
Sentiment: Neutral
Argenx SE is a biotechnology company best known for developing Vyvgart, the leading FcRn inhibitor for the treatment of autoimmune conditions. RadNet, Inc. is the largest operator of outpatient diagnostic imaging services and related solutions in the U.S. Intuitive Surgical, Inc. manufactures the da Vinci Surgical System, a robotic surgical system used for minimally invasive surgical procedures.
Read More
Best Momentum Stock to Buy for Oct. 27th
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive
PRM, GM and ISRG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 27, 2025.
Read More
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
Why Intuitive Surgical Stock Zoomed 23% Higher This Week
Published: October 24, 2025 by: The Motley Fool
Sentiment: Positive
Intuitive Surgical stock rose over 20% this week on earnings. The company's revenue is accelerating with strong profit margins.
Read More
Intuitive Surgical Is A Buy Despite Post-Earnings Surge
Published: October 23, 2025 by: Seeking Alpha
Sentiment: Positive
Intuitive Surgical is a leader at the intersection of robotics, AI, and healthcare, driving innovation with products like da Vinci 5 and Ion. ISRG's strong adoption metrics, accelerating revenue and EPS growth, and robust recurring revenues highlight its operational excellence and customer value. Despite a premium to sector valuations, ISRG trades below its five-year average P/E, offering potential for multiple expansion.
Read More
Top Stock Movers Now: Netflix, Texas Instruments, Intuitive Surgical, and More
Published: October 22, 2025 by: Investopedia
Sentiment: Negative
Major U.S. equities indexes slid Wednesday afternoon after a flurry of weaker-than-expected earnings reports. The Dow, S&P 500, and Nasdaq all declined.
Read More
Intuitive Surgical Q3 Results Ease Bear Market Concerns, Analyst Views 'Headwinds As Largely Noise'
Published: October 22, 2025 by: Benzinga
Sentiment: Positive
Intuitive Surgical (NASDAQ:ISRG) reported revenue of $2.51 billion for the third quarter, up 23% year-over-year, beating analyst estimates of $2.40 billion.
Read More
Intuitive Surgical's Stock Jumps As Demand for Robotic Procedures Rises
Published: October 22, 2025 by: Investopedia
Sentiment: Positive
Intuitive Surgical (ISRG) shares jumped Wednesday after the maker of robotic surgical devices posted much better-than-expected quarterly results and raised its guidance on increased use of its units.
Read More
ISRG Stock Gains on Q3 Earnings & Revenue Beat, Gross Margin Declines
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical's shares jump 17% after Q3 earnings and revenues beat expectations, fueled by surging da Vinci 5 placements and strong global procedure growth.
Read More
Why Intuitive Surgical Is a No-Brainer for Long-Term Investors
Published: October 22, 2025 by: MarketBeat
Sentiment: Positive
Intuitive Surgical NASDAQ: ISRG is intuitively a good buy-and-hold stock because its industry-leading, in-demand products and services generate robust cash flow, driving consistent gains in shareholder value. The value is evident in its balance sheet and cash flow metrics, which enable it to buy back shares while investing in growth and maintaining one of the healthiest balance sheets on Wall Street.
Read More
Here's What Key Metrics Tell Us About Intuitive Surgical (ISRG) Q3 Earnings
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Intuitive Surgical (ISRG) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Intuitive Surgical shares soar after upbeat earnings: should you buy?
Published: October 22, 2025 by: Invezz
Sentiment: Positive
Shares of Intuitive Surgical jumped more than 17% in premarket trading on Wednesday after the robotic surgery pioneer reported stronger-than-expected third-quarter earnings, fuelled by the rising adoption of its flagship da Vinci system and expanding global demand for robotic-assisted procedures. The California-based company posted adjusted earnings of $2.40 per share, surpassing the $1.
Read More
Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?
Published: October 17, 2025 by: Zacks Investment Research
Sentiment: Neutral
Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.
Read More
Can Ion Emerge as ISRG's Vehicle to Tap Ambulatory Care Growth?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical's Ion platform gains traction in ambulatory centers, driving 52% growth as outpatient lung diagnostics accelerate.
Read More
High Margins, Lower Price: Is Intuitive Surgical Stock A Buy?
Published: October 14, 2025 by: Forbes
Sentiment: Positive
Intuitive Surgical (ISRG) stock deserves your consideration. Why? Because you get monopoly-like high margins for a discounted price.
Read More
Can ISRG Continue Its Strong Growth Amid Tariff & Rare Earth Woes?
Published: October 14, 2025 by: Zacks Investment Research
Sentiment: Neutral
ISRG's growth momentum faces pressure as tariffs and China's rare earth export curbs threaten margins and supply stability.
Read More
ISRG Shares Rise as FDA Clears AI Integration for Ion Platform
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical shares climb after FDA clears AI-driven upgrades for its Ion platform, boosting precision and efficiency in lung biopsies.
Read More
Intuitive Surgical, Inc. (ISRG) to Report Q3 Results: Wall Street Expects Earnings Growth
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical (ISRG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
ISRG Bets on SP Platform to Capture Rising ASC Procedure Volume
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical's SP platform is gaining traction as a cost-efficient, high-throughput option for ASCs, complementing da Vinci 5 in hospitals.
Read More
Intuitive expands AI and advanced imaging integration in Ion Endoluminal System
Published: October 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
FDA-cleared software release enhances navigation and broadens access to advanced imaging for lung biopsy procedures FDA-cleared software release enhances navigation and broadens access to advanced imaging for lung biopsy procedures
Read More
Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?
Published: October 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
ISRG Expands SP Indications: A Game Changer in Colorectal Surgery?
Published: October 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Intuitive Surgical's SP platform secures new colorectal clearances, with 88% growth in procedures and rising global adoption momentum.
Read More
Is Intuitive Surgical the Hidden Winner in Healthcare's Weakness?
Published: October 01, 2025 by: MarketBeat
Sentiment: Neutral
The medical sector in the United States has been heavily affected by a bearish cycle, driven by scandals surrounding the GLP-1 drugs used in weight loss solutions for consumers. As more companies are exposed to the manufacturing and distribution of these drugs, even some unrelated names have been dragged down by this broader sentiment, creating massive opportunities for those who are bold enough to look into the space.
Read More
ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
Published: September 29, 2025 by: Zacks Investment Research
Sentiment: Positive
The robotic surgery market is undergoing rapid transformation, driven by technological advancements, increasing adoption in hospitals, and a shift toward minimally invasive procedures. As of 2025, it's growing rapidly, focusing on precision, AI integration, and expanding its use across specialties like urology, gynecology, orthopedics, and general surgery.
Read More
About Intuitive Surgical, Inc. (ISRG)
- IPO Date 2000-06-16
- Website https://www.intuitive.com
- Industry Medical - Instruments & Supplies
- CEO Gary S. Guthart
- Employees 15638